157 related articles for article (PubMed ID: 7492105)
21. [Current Streptococcus pyogenes sensitivity responsible for acute tonsillopharyngitis in France].
Mariani-Kurkdjian P; Doit C; Deforche D; Brahimi N; Francois M; Van den Abbeele T; Bingen E
Presse Med; 2004 Jun; 33(11):703-6. PubMed ID: 15257225
[TBL] [Abstract][Full Text] [Related]
22. In vitro protection of group A beta-hemolytic streptococci from penicillin and cephalothin by Bacteroides fragilis.
Brook I; Yokum P
Chemotherapy; 1983; 29(1):18-23. PubMed ID: 6339177
[TBL] [Abstract][Full Text] [Related]
23. Meta-analysis of cephalosporin versus penicillin treatment of group A streptococcal tonsillopharyngitis in children.
Casey JR; Pichichero ME
Pediatrics; 2004 Apr; 113(4):866-82. PubMed ID: 15060239
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of penicillin vs. amoxicillin in children with group A beta hemolytic streptococcal tonsillopharyngitis.
Curtin-Wirt C; Casey JR; Murray PC; Cleary CT; Hoeger WJ; Marsocci SM; Murphy ML; Francis AB; Pichichero ME
Clin Pediatr (Phila); 2003 Apr; 42(3):219-25. PubMed ID: 12739920
[TBL] [Abstract][Full Text] [Related]
25. Antibacterial therapy for acute group a streptococcal pharyngotonsillitis: short-course versus traditional 10-day oral regimens.
Brook I
Paediatr Drugs; 2002; 4(11):747-54. PubMed ID: 12390046
[TBL] [Abstract][Full Text] [Related]
26. A pooled comparison of cefdinir and penicillin in the treatment of group a beta-hemolytic streptococcal pharyngotonsillitis.
Brook I
Clin Ther; 2005 Aug; 27(8):1266-73. PubMed ID: 16199251
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of bacterial interference and beta-lactamase production in management of experimental infection with group A beta-hemolytic streptococci.
Brook I; Gilmore JD
Antimicrob Agents Chemother; 1993 Jul; 37(7):1452-5. PubMed ID: 8363375
[TBL] [Abstract][Full Text] [Related]
28. Cefetamet pivoxil in the treatment of pharyngotonsillitis due to group A beta-hemolytic streptococci: preliminary report.
Gervaix A; Brighi L; Halpérin DS; Suter S
J Chemother; 1995 May; 7 Suppl 1():21-4. PubMed ID: 8618109
[TBL] [Abstract][Full Text] [Related]
29. Loracarbef versus penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis in adults.
McCarty J; Hernon Y; Linn L; Therasse DG; Molina A; Bleile N
Clin Ther; 1992; 14(1):30-40. PubMed ID: 1576624
[TBL] [Abstract][Full Text] [Related]
30. Rate of eradication of group A beta-hemolytic streptococci in children with pharyngo-tonsillitis by amoxicillin and cefdinir.
Brook I; Gober AE
Int J Pediatr Otorhinolaryngol; 2009 May; 73(5):757-9. PubMed ID: 19285734
[TBL] [Abstract][Full Text] [Related]
31. Five days of erythromycin estolate versus ten days of penicillin V in the treatment of group A streptococcal tonsillopharyngitis in children. Pharyngitis Study Group.
Adam D; Scholz H
Eur J Clin Microbiol Infect Dis; 1996 Sep; 15(9):712-7. PubMed ID: 8922570
[TBL] [Abstract][Full Text] [Related]
32. Recovery of interfering and beta-lactamase-producing bacteria from group A beta-haemolytic streptococci carriers and non-carriers.
Brook I; Gober AE
J Med Microbiol; 2006 Dec; 55(Pt 12):1741-1744. PubMed ID: 17108280
[TBL] [Abstract][Full Text] [Related]
33. Streptococcal pharyngitis: is penicillin still the drug of choice?
Rajesh KR; Gordon RC
Indian J Pediatr; 1996; 63(4):437-40. PubMed ID: 10832462
[TBL] [Abstract][Full Text] [Related]
34. Penicillin tolerance and treatment failure in group A streptococcal pharyngotonsillitis.
van Asselt GJ; Mouton RP; van Boven CP
Eur J Clin Microbiol Infect Dis; 1996 Feb; 15(2):107-15. PubMed ID: 8801081
[TBL] [Abstract][Full Text] [Related]
35. Multicentre evaluation of azithromycin and penicillin V in the treatment of acute streptococcal pharyngitis and tonsillitis in children.
Hamill J
J Antimicrob Chemother; 1993 Jun; 31 Suppl E():89-94. PubMed ID: 8396102
[TBL] [Abstract][Full Text] [Related]
36. The presence of beta-lactamase-producing bacteria as a guideline in the management of children with recurrent tonsillitis.
Brook I
Am J Otolaryngol; 1984; 5(6):382-6. PubMed ID: 6400716
[TBL] [Abstract][Full Text] [Related]
37. Group A beta-hemolytic streptococcal infections.
Pichichero ME
Pediatr Rev; 1998 Sep; 19(9):291-302. PubMed ID: 9745311
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of 5-day therapy with telithromycin, a novel ketolide antibacterial, for the treatment of tonsillopharyngitis.
Norrby SR; Quinn J; Rangaraju M; Leroy B
Clin Microbiol Infect; 2004 Jul; 10(7):615-23. PubMed ID: 15214873
[TBL] [Abstract][Full Text] [Related]
39. Increased recovery of Moraxella catarrhalis and Haemophilus influenzae in association with group A beta-haemolytic streptococci in healthy children and those with pharyngo-tonsillitis.
Brook I; Gober AE
J Med Microbiol; 2006 Aug; 55(Pt 8):989-992. PubMed ID: 16849717
[TBL] [Abstract][Full Text] [Related]
40. Strategies for managing group A streptococcal pharyngitis. A survey of board-certified pediatricians.
Hofer C; Binns HJ; Tanz RR
Arch Pediatr Adolesc Med; 1997 Aug; 151(8):824-9. PubMed ID: 9265886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
